Trials / Unknown
UnknownNCT02111148
Vaginal Fluid Wash in Pre-labour Rupture of Membranes
Urea and Creatinine Versus Nitrazine Test in Vaginal Fluid Wash in Diagnosed Pre Labour Rupture of Membranes
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 105 (estimated)
- Sponsor
- Beni-Suef University · Academic / Other
- Sex
- Female
- Age
- 30 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The investigators assess in this study the sensitivity of Urea and Creatinine and that of Nitrazine test in vaginal wash after injecting saline in the vagina of patients with pre-labour rupture of membranes
Detailed description
The aim of this study is to compare the accuracy of measuring the urea and creatinine level versus that of nitrazine test in vaginal wash of pre-labour rupture of membranes patients.Each patient with rupture of membranes will be assessed clinically and then if not in labour , patients will be divided into 2 groups, 5ml saline will be injected in the vagina of each patient in every group then the vaginal wash will be collected in a test tube. Urea and creatinine group, biochemical tests for urea and creatinine in mIU/ml to detect their presence in the wash will be done. In Nitrazine group wash will be assessed by nitrazine paper showing bluish discoloration in rupture membranes. Sensitivity of each test in diagnosed rupture of membranes will be assessed.Which means how many patients in each test show positive results in case of diagnosed case.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Urea and creatinine | the vagina will be washed with 5ml saline, urea and creatinine will be detected biochemically in the vaginal wash. |
| PROCEDURE | Nitrazine | Nitrazine detection in vaginal wash |
| DRUG | 5ml saline | the vagina will be washed with 5ml saline and vaginal wash will be collected. |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2014-04-11
- Last updated
- 2021-02-16
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02111148. Inclusion in this directory is not an endorsement.